Atossa Genetics intends to raise $6 million by issuing 1 million shares of stock in its IPO, according to SEC filings. The Seattle-based biotech makes breast cancer diagnostic tests and treatments.
Atossa plans $6 million IPO
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|